Baidu
map

2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用

2021-02-16 国际血脂专家组 Pharmacol Res . 2021 Feb 16;

2021年2月,国际血脂专家组(ILEP)发布了急性冠脉综合征后降脂治疗的最佳应用意见书,动脉粥样硬化性心血管疾病(ASCVD)以及其引起的急性冠脉综合征(ACS)可通过降脂治疗降低血多疾病负担。本文

中文标题:

2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用

英文标题:

OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

发布机构:

国际血脂专家组

发布日期:

2021-02-16

简要介绍:

2021年2月,国际血脂专家组(ILEP)发布了急性冠脉综合征后降脂治疗的最佳应用意见书,动脉粥样硬化性心血管疾病(ASCVD)以及其引起的急性冠脉综合征(ACS)可通过降脂治疗降低血多疾病负担。本文主要目的是对急性关门综合征患者现有降脂治疗指导进行补充,并提出了具体治疗方案,以改善这些患者接受降脂治疗的机会和依从性。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9e8e11c002065a6e, title=2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用, enTitle=OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP), guiderFrom=Pharmacol Res . 2021 Feb 16;, authorId=0, author=, summary=2021年2月,国际血脂专家组(ILEP)发布了急性冠脉综合征后降脂治疗的最佳应用意见书,动脉粥样硬化性心血管疾病(ASCVD)以及其引起的急性冠脉综合征(ACS)可通过降脂治疗降低血多疾病负担。本文, cover=https://img.medsci.cn/202135/1614873968815_2020535.jpg, journalId=0, articlesId=null, associationId=1892, associationName= 国际血脂专家组, associationIntro=国际血脂专家组(ILEP,International Lipid Expert Panel), copyright=0, guiderPublishedTime=Tue Feb 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月,国际血脂专家组(ILEP)发布了急性冠脉综合征后降脂治疗的最佳应用意见书,动脉粥样硬化性心血管疾病(ASCVD)以及其引起的急性冠脉综合征(ACS)可通过降脂治疗降低血多疾病负担。本文主要目的是对急性关门综合征患者现有降脂治疗指导进行补充,并提出了具体治疗方案,以改善这些患者接受降脂治疗的机会和依从性。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=360, tagName=急性冠脉综合征)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=360, guiderKeyword=急性冠脉综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16174, appHits=246, showAppHits=0, pcHits=985, showPcHits=15928, likes=2, shares=8, comments=25, approvalStatus=1, publishedTime=Fri Mar 05 00:24:21 CST 2021, publishedTimeString=2021-02-16, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Fri Mar 05 00:06:15 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 23:35:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用.pdf)])
2021 ILEP意见书:急性冠脉综合征后降脂治疗的最佳应用.pdf
下载请点击:
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079980, encodeId=894b10e9980d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9z5DicxEJgptjgdKOlRP6XOIicpq6xo5JgqR5QLD0FtUWlAcxow6jD2icMOfwTY1ZSmUPVXdibtFiaag/132, createdBy=50112399782, createdName=房房, createdTime=Tue Dec 14 15:54:16 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016300, encodeId=b85c1016300fd, content=NND,也不注明是英文版,骗积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/b39c8bc0ab334969ba4ccc08e7a6cd94/c4e41798ef27449aa31ad740c9b13062.jpg, createdBy=5ff35133022, createdName=forvalen, createdTime=Fri Sep 10 12:39:24 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006856, encodeId=d14b100685620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Wed Aug 11 08:51:05 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004088, encodeId=483a10040886e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210730/cfa582b75af14673b2bc56dd7553ef77/0c75f1a68c47497cb8519a3c2a50d865.jpg, createdBy=900a5472985, createdName=yuyio, createdTime=Fri Jul 30 22:22:35 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004048, encodeId=7a311004048a8, content=<a href='/topic/show?id=9f5d309954b' target=_blank style='color:#2F92EE;'>#冠脉综合征#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30995, encryptionId=9f5d309954b, topicName=冠脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:05:33 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-12-14 房房

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079980, encodeId=894b10e9980d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9z5DicxEJgptjgdKOlRP6XOIicpq6xo5JgqR5QLD0FtUWlAcxow6jD2icMOfwTY1ZSmUPVXdibtFiaag/132, createdBy=50112399782, createdName=房房, createdTime=Tue Dec 14 15:54:16 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016300, encodeId=b85c1016300fd, content=NND,也不注明是英文版,骗积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/b39c8bc0ab334969ba4ccc08e7a6cd94/c4e41798ef27449aa31ad740c9b13062.jpg, createdBy=5ff35133022, createdName=forvalen, createdTime=Fri Sep 10 12:39:24 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006856, encodeId=d14b100685620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Wed Aug 11 08:51:05 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004088, encodeId=483a10040886e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210730/cfa582b75af14673b2bc56dd7553ef77/0c75f1a68c47497cb8519a3c2a50d865.jpg, createdBy=900a5472985, createdName=yuyio, createdTime=Fri Jul 30 22:22:35 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004048, encodeId=7a311004048a8, content=<a href='/topic/show?id=9f5d309954b' target=_blank style='color:#2F92EE;'>#冠脉综合征#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30995, encryptionId=9f5d309954b, topicName=冠脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:05:33 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-09-10 forvalen

    NND,也不注明是英文版,骗积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079980, encodeId=894b10e9980d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9z5DicxEJgptjgdKOlRP6XOIicpq6xo5JgqR5QLD0FtUWlAcxow6jD2icMOfwTY1ZSmUPVXdibtFiaag/132, createdBy=50112399782, createdName=房房, createdTime=Tue Dec 14 15:54:16 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016300, encodeId=b85c1016300fd, content=NND,也不注明是英文版,骗积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/b39c8bc0ab334969ba4ccc08e7a6cd94/c4e41798ef27449aa31ad740c9b13062.jpg, createdBy=5ff35133022, createdName=forvalen, createdTime=Fri Sep 10 12:39:24 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006856, encodeId=d14b100685620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Wed Aug 11 08:51:05 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004088, encodeId=483a10040886e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210730/cfa582b75af14673b2bc56dd7553ef77/0c75f1a68c47497cb8519a3c2a50d865.jpg, createdBy=900a5472985, createdName=yuyio, createdTime=Fri Jul 30 22:22:35 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004048, encodeId=7a311004048a8, content=<a href='/topic/show?id=9f5d309954b' target=_blank style='color:#2F92EE;'>#冠脉综合征#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30995, encryptionId=9f5d309954b, topicName=冠脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:05:33 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-08-11 向阳花开

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079980, encodeId=894b10e9980d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9z5DicxEJgptjgdKOlRP6XOIicpq6xo5JgqR5QLD0FtUWlAcxow6jD2icMOfwTY1ZSmUPVXdibtFiaag/132, createdBy=50112399782, createdName=房房, createdTime=Tue Dec 14 15:54:16 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016300, encodeId=b85c1016300fd, content=NND,也不注明是英文版,骗积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/b39c8bc0ab334969ba4ccc08e7a6cd94/c4e41798ef27449aa31ad740c9b13062.jpg, createdBy=5ff35133022, createdName=forvalen, createdTime=Fri Sep 10 12:39:24 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006856, encodeId=d14b100685620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Wed Aug 11 08:51:05 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004088, encodeId=483a10040886e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210730/cfa582b75af14673b2bc56dd7553ef77/0c75f1a68c47497cb8519a3c2a50d865.jpg, createdBy=900a5472985, createdName=yuyio, createdTime=Fri Jul 30 22:22:35 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004048, encodeId=7a311004048a8, content=<a href='/topic/show?id=9f5d309954b' target=_blank style='color:#2F92EE;'>#冠脉综合征#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30995, encryptionId=9f5d309954b, topicName=冠脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:05:33 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-07-30 yuyio

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079980, encodeId=894b10e9980d9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9z5DicxEJgptjgdKOlRP6XOIicpq6xo5JgqR5QLD0FtUWlAcxow6jD2icMOfwTY1ZSmUPVXdibtFiaag/132, createdBy=50112399782, createdName=房房, createdTime=Tue Dec 14 15:54:16 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016300, encodeId=b85c1016300fd, content=NND,也不注明是英文版,骗积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/b39c8bc0ab334969ba4ccc08e7a6cd94/c4e41798ef27449aa31ad740c9b13062.jpg, createdBy=5ff35133022, createdName=forvalen, createdTime=Fri Sep 10 12:39:24 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006856, encodeId=d14b100685620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Wed Aug 11 08:51:05 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004088, encodeId=483a10040886e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210730/cfa582b75af14673b2bc56dd7553ef77/0c75f1a68c47497cb8519a3c2a50d865.jpg, createdBy=900a5472985, createdName=yuyio, createdTime=Fri Jul 30 22:22:35 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004048, encodeId=7a311004048a8, content=<a href='/topic/show?id=9f5d309954b' target=_blank style='color:#2F92EE;'>#冠脉综合征#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30995, encryptionId=9f5d309954b, topicName=冠脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:05:33 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

拓展阅读

2013 ACCF/AHA 急性冠脉综合征和冠状动脉疾病患者的临床管理和转归关键数据元素和定义

美国心脏病学会基金会(ACCF,American College of Cardiology Foundation) · 2013-02-26

2014 AHA科学声明:抑郁是急性冠脉综合征预后不良的危险因素

美国心脏协会(AHA,American Heart Association) · 2014-02-24

2014 EHRA/ACCA/EAPCI意见书:急性冠脉综合征患者的心律失常

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2014-08-29

2014 ACC/AHA非ST段抬高型急性冠脉综合征(NSTE-ACS)患者管理指南

美国心脏病学会(ACC,American College of Cardiology) · 2014-09-23

2015 AHA科学声明:慢性肾病患者急性冠脉综合征的药物治疗

美国心脏协会(AHA,American Heart Association) · 2015-02-24

Baidu
map
Baidu
map
Baidu
map